Chicago Capital Management’s Astria Therapeutics ATXS Stock Holding History

Chicago Capital Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-530,000	Closed	-$5.24M	–	31
2025 Q4	$5.24M	Buy	+530,000	New	+$6.33M	3.56%	13

Chicago Capital Management's ATXS Position: Q1 2026 in Review

Chicago Capital Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 530,000 shares — an estimated $5.24M sold.

Chicago Capital Management first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $5.24M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Chicago Capital Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Chicago Capital Management sold 530,000 Astria Therapeutics shares in Q1 2026, an estimated $5.24M.
Chicago Capital Management first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Chicago Capital Management's Astria Therapeutics position peaked at $5.24M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Chicago Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.